56 Improvement of prognosis irrespective of age in early node negative early breast cancer by adjuvant high-dose medroxyprogesterone acetate (HD-MPA); ten years results of a multicenter randomized trial

✍ Scribed by C. Focan; M. Beauduin; E. Salamon; J. de Grève; G. de Wasch; P. Lobelle; F. Majois; A. Tagnon; J. Tytgat; S. van Belle; R. Vandervellen; A. Vindevoghel

• Book ID: 116166812
• Publisher: Elsevier Science
• Year: 1995
• Tongue: English
• Weight: 162 KB
• Volume: 31
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/0959-8049(95)95308-s